NOTABLE LABS LTD

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NTBLQ and buy or sell other stocks, ETFs, and their options commission-free!

About NTBLQ

Notable Labs Ltd. is a clinical-stage platform therapeutics company that develops predictive medicines for patients with cancer. Through its proprietary Predictive Medicines Platform, the firm predicts whether or not that patient is likely to respond to that specific therapeutic. 

CEO
Kaile A. Zagger
CEOKaile A. Zagger
Employees
Employees
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
2000
Founded2000
Employees
Employees

NTBLQ Key Statistics

Market cap
965.95
Market cap965.95
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
110.60
Average volume110.60
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.001
52 Week high$0.001
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

As of today, NOTABLE LABS LTD(NTBLQ) shares are valued at $0.00. The company's market cap stands at 965.95.

During the trading day, NOTABLE LABS LTD(NTBLQ) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 110.6.

The stock's 52-week range extends from a low of $0.00 to a high of $0.00.

The stock's 52-week range extends from a low of $0.00 to a high of $0.00.

People also own

Based on the portfolios of people who own NTBLQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.